Inovio Pharmaceuticals(us:INO)
1.78
-3.26%
Updated on 2024-12-23
Open:1.82
Close:1.78
High:1.83
Low:1.76
Pre Close:1.84
Volume:507481.00
Amount:913676.94
Turnover:1.41%
Shares:36.10M
MarketCap:64.44M
About Inovio Pharmaceuticals Company
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
Company Name: Inovio Pharmaceuticals
Company Address: 660 West Germantown Pike,Suite 110
Employees: 122
Fiscar Year: 12-31
IPO Date: 1998-12-08
Website: http://www.inovio.com
CIK: 1055726
View all SEC Filings
About
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
Address:660 West Germantown Pike,Suite 110
Website:http://www.inovio.com
Market Movers